P-762. Comparative Analysis Of Inpatient mortality, 30-Day And 60-Day Re-admissions in Diabetic Ketoacidosis (DKA) Patients with Urinary Tract Infections And Pneumonia
Chinar Singh, Hamza Khan, Danish Saeed, Magyury Gomez, Amogh Killedar, Martin Andrew

TL;DR
This study compares how different infections affect outcomes in patients with diabetic ketoacidosis, finding that viral pneumonia significantly increases in-hospital mortality.
Contribution
The study provides a comparative analysis of inpatient mortality and readmission rates in DKA patients with specific infections.
Findings
Viral pneumonia was associated with significantly higher in-hospital mortality compared to bacterial pneumonia.
No significant differences in 30 or 60-day readmission rates were found between infection types.
Infection type influenced in-hospital outcomes but not readmission risk.
Abstract
Diabetic ketoacidosis (DKA), a life-threatening diabetes complication, is often triggered by infections— which cause nearly half of cases —often pneumonia and UTIs. Infections worsen DKA severity, prolong hospital stays, and increase mortality. Despite this, few studies compare DKA outcomes by infection type. This study analyzes infection-related DKA, focusing on UTIs and pneumonias, and evaluates their impact on in-hospital mortality and 30-/60-day readmission rates. Results for mortality , 30-/60-day readmission ratesGraph comparing ODDS ratio among infections for mortality 30-/60-day readmission rates Graph comparing ODDS ratio among infections for mortality 30-/60-day readmission rates This retrospective cohort study included adults (≥18 years) admitted with DKA and a concurrent infection—pyelonephritis, cystitis, bacterial viral pneumonia at HCA East Florida facilities from…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes and associated disorders · Gut microbiota and health · Chronic Disease Management Strategies
